NDLI: Laboratory diagnosis of coronavirus disease-2019 (COVID-19)

Please wait, while we are loading the content...

Laboratory diagnosis of coronavirus disease-2019 (COVID-19)

Content Provider	Scilit
Author	Li, Chenxi Zhao, Chengxue Bao, Jingfeng Tang, Bo Wang, Yunfeng Gu, Bing
Copyright Year	2020
Description	Journal: Clinica Chimica Acta; International Journal of Clinical Chemistry The outbreak of Coronavirus Disease-2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) has threatened health worldwide. As of the end of 2020, there were nearly 10 million confirmed cases and nearly 5 million deaths associated with COVID-19. Rapid and early laboratory diagnosis of COVID-19 is the main focus of treatment and control. Molecular tests are the basis for confirmation of COVID-19, but serological tests for SARS-CoV-2 are widely available and play an increasingly important role in understanding the epidemiology of the virus and in identifying populations at higher risk for infection. Point-of-care tests have the advantage of rapid, accurate, portable, low cost and non-specific device requirements, which provide great help for disease diagnosis and detection. This review will discuss the performance of different laboratory diagnostic tests and platforms, as well as suitable clinical samples for testing, and related biosafety protection. This review shall guide for the diagnosis of COVID-19 caused by SARS-CoV-2.
Related Links	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7329657/pdf
Ending Page	46
Page Count	12
Starting Page	35
ISSN	00098981
e-ISSN	18733492
DOI	10.1016/j.cca.2020.06.045
Journal	Clinica Chimica Acta; International Journal of Clinical Chemistry
Volume Number	510
Language	English
Publisher	Elsevier BV
Publisher Date	2020-07-02
Access Restriction	Open
Subject Keyword	Journal: Clinica Chimica Acta; International Journal of Clinical Chemistry Medical Laboratory Technology Laboratory Diagnosis
Content Type	Text
Resource Type	Article
Subject	Biochemistry (medical) Clinical Biochemistry Biochemistry

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Laboratory findings in COVID-19 diagnosis and prognosis

COVID-19: Review and hematologic impact

Update on serologic testing in COVID–19

Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19

C-reactive protein: A promising biomarker for poor prognosis in COVID-19 infection

SARS-CoV-2 antibody characterization in emergency department, hospitalized and convalescent patients by two semi-quantitative immunoassays

COVID-19 infection and thrombosis

Dynamic changes in routine blood parameters of a severe COVID-19 case

Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection

Laboratory diagnosis of coronavirus disease-2019 (COVID-19)

Similar Documents

Laboratory findings in COVID-19 diagnosis and prognosis

COVID-19: Review and hematologic impact

Update on serologic testing in COVID–19

Comparative analysis of laboratory indexes of severe and non-severe patients infected with COVID-19

C-reactive protein: A promising biomarker for poor prognosis in COVID-19 infection

SARS-CoV-2 antibody characterization in emergency department, hospitalized and convalescent patients by two semi-quantitative immunoassays

COVID-19 infection and thrombosis

Dynamic changes in routine blood parameters of a severe COVID-19 case

Declined serum high density lipoprotein cholesterol is associated with the severity of COVID-19 infection

Laboratory diagnosis of coronavirus disease-2019 (COVID-19)